Dit is ons nieuw hondje Kira, een kruising van een waterhond en een Podenko. Ze is sinds 7 februari 2024 bij ons en druk bezig ons hart te veroveren. Het is een lief, aanhankelijk hondje, dat zich op een week snel aan ons heeft aangepast. Ze is heel vinnig en nieuwsgierig, een heel ander hondje dan Noleke.
This is our new dog Kira, a cross between a water dog and a Podenko. She has been with us since February 7, 2024 and is busy winning our hearts. She is a sweet, affectionate dog who quickly adapted to us within a week. She is very quick and curious, a very different dog than Noleke.
DEAR VISITOR,
MY BLOG EXISTS ALREADY 13 YEARS AND 2 MONTH.
ON 06/08/2024 MORE THAN 2.161.100
VISITORS FROM 135 DIFFERENT NATIONS ALREADY FOUND THEIR WAY TO MY BLOG.
THAT IS AN AVERAGE OF 400GUESTS PER DAY.
THANK YOU FOR VISITING MY BLOG AND HOPE YOU ENJOY EACH TIME.
The purpose of this blog is the creation of an open, international, independent and free forum, where every UFO-researcher can publish the results of his/her research. The languagues, used for this blog, are Dutch, English and French.You can find the articles of a collegue by selecting his category. Each author stays resposable for the continue of his articles. As blogmaster I have the right to refuse an addition or an article, when it attacks other collegues or UFO-groupes.
Druk op onderstaande knop om te reageren in mijn forum
Zoeken in blog
Deze blog is opgedragen aan mijn overleden echtgenote Lucienne.
In 2012 verloor ze haar moedige strijd tegen kanker!
In 2011 startte ik deze blog, omdat ik niet mocht stoppen met mijn UFO-onderzoek.
BEDANKT!!!
Een interessant adres?
UFO'S of UAP'S, ASTRONOMIE, RUIMTEVAART, ARCHEOLOGIE, OUDHEIDKUNDE, SF-SNUFJES EN ANDERE ESOTERISCHE WETENSCHAPPEN - DE ALLERLAATSTE NIEUWTJES
UFO's of UAP'S in België en de rest van de wereld In België had je vooral BUFON of het Belgisch UFO-Netwerk, dat zich met UFO's bezighoudt. BEZOEK DUS ZEKER VOOR ALLE OBJECTIEVE INFORMATIE , enkel nog beschikbaar via Facebook en deze blog.
Verder heb je ook het Belgisch-Ufo-meldpunt en Caelestia, die prachtig, doch ZEER kritisch werk leveren, ja soms zelfs héél sceptisch...
Voor Nederland kan je de mooie site www.ufowijzer.nl bezoeken van Paul Harmans. Een mooie site met veel informatie en artikels.
MUFON of het Mutual UFO Network Inc is een Amerikaanse UFO-vereniging met afdelingen in alle USA-staten en diverse landen.
MUFON's mission is the analytical and scientific investigation of the UFO- Phenomenon for the benefit of humanity...
Je kan ook hun site bekijken onder www.mufon.com.
Ze geven een maandelijks tijdschrift uit, namelijk The MUFON UFO-Journal.
Since 02/01/2020 is Pieter ex-president (=voorzitter) of BUFON, but also ex-National Director MUFON / Flanders and the Netherlands. We work together with the French MUFON Reseau MUFON/EUROP.
ER IS EEN NIEUWE GROEPERING DIE ZICH BUFON NOEMT, MAAR DIE HEBBEN NIETS MET ONZE GROEP TE MAKEN. DEZE COLLEGA'S GEBRUIKEN DE NAAM BUFON VOOR HUN SITE... Ik wens hen veel succes met de verdere uitbouw van hun groep. Zij kunnen de naam BUFON wel geregistreerd hebben, maar het rijke verleden van BUFON kunnen ze niet wegnemen...
27-01-2017
Soon printing a human heart on demand will no longer be sci-fi
Soon printing a human heart on demand will no longer be sci-fi
Julian Littler, special to CNBC.com
Sebastian Kaulitzk | Getty Images
Imagine being able to grow a liver in a laboratory from cells and tissue for a transplant patient. Or engineering cells to grow into a heart valve to replace one damaged from heart disease. Around the world, start-ups — like Tokyo-based Cyfuse Biomedical — are emerging to develop such breakthroughs in the field of regenerative medicine. It is a market projected to reach $101.3 billion by 2022.
Unlike conventional medicines and treatments, regenerative medicines have the ability to restore or heal the body's own cells or create new body parts from a patient's own cells and tissues, thereby eliminating tissue rejection and the excessively long wait for a donor organ.
It may sound like science fiction, but already scientists at Cyfuse have bioprinted blood vessels able to withstand 10 times the pressure of those already in the human body, according to Koji Kuchiishi, co-founder and former CEO.
Bioprinting works like this: Scientists harvest human cells from biopsies or stem cells, then allow them to multiply in a petri dish. The resulting mixture, a sort of biological ink, is fed into a 3-D printer that is programmed to arrange different cell types and materials into a three-dimensional shape. Doctors hope that when placed into the body, these 3-D printed cells will integrate with existing tissue.
While breakthroughs in central nervous system and cardiac treatments remain in the future for now, Cyfuse's Regenova bioprinter is attracting attention from the scientific community. The bioprinter is a robotic system that facilitates the fabrication of 3-D cellular structures by placing cellular spheroids in fine needle arrays according to predesigned 3-D data. Among Cyfuse's goals: to treat spinal injuries and heart failure.
This year the company transplanted human neural tissue into the brain of a small animal with positive results. Blood vessels migrated into the transplanted tissue and the graft was healing after a month.
Cyfuse has also started a clinical trial of a cartilage project, transplanting its stem cell construct into damaged articular cartilage that will gradually differentiate into cartilage and bone and regenerate the tissue.
Cyfuse is one of a growing number of tech start-ups trying to get a toehold in the global marketplace. The sector is blossoming due to innovations in stem cell therapy and tissue engineering. North America accounted for nearly 50 percent of revenue share of global market revenues for regenerative medicines in 2016. Europe is second, at US$24 billion, with Germany leading the region.
Japan and South Korea are steadily gaining ground, however. Japan's Ministry of Economy, Trade and Industry forecasts the regenerative medicine market to grow to 1 trillion yen ($9.6 billion) domestically by 2030.
With technological adoption and emphasis on research of these medicines, Asia-Pacific is currently one of the fastest-growing regions for regenerative medicine.
The medical power of Japanese art
While there are several companies around the globe leading the 3-D bioprinting space — including Organovo in San Diego, Aspect Biosystems in Vancouver, 3D Bioprinting Solutions in Russia and Rokit in South Korea — Cyfuse says its Kenzan method, a proprietary technique developed by Cyfuse co-founder and human tissue engineer, Koichi Nakayama, differentiates it from the pack.
Named after the spikes used to secure flowers in place in the Japanese art of Ikebana, Kenzan relies on the cultivation of cell aggregates into spheroids that are skewered on stainless-steel spines in the bioprinter.
Regenova is also scaffold-free, meaning the printer fabricates tissue without needing to add any extraneous matter that might pollute it. And unlike many of the other bioprinters, there is no need for collagen or hydrogels; the cells produce their own extracellular matrix.
"To unlock the potential [of bioprinting], it's going to take the marriage between the machine and the imagination of scientists."
-Dr. David Yu, vice president of business development at Cell Applications
In February 2016, San Diego-based Cell Applications became the first U.S. company to use Regenova. In the same month, Virginia-based Lifenet, an institution specializing in regenerative medicine and transplants, became the first buyer anywhere in the world to purchase the system.
"I did a market assessment and review and reached out to a number of companies, including Cyfuse," said Cell Applications' vice president of sales and marketing Daniel Schroen, Ph.D. "Some of them were pretty far upstream from commercialization."
The Californian company is using the bioprinter to create 3-D tissue for a range of clients spanning academic and corporate research.
"We've printed small, tiny beating heart tissue here. We've also printed blood vessels," explained Dr. Schroen.
Medical schools are finding uses for the bioprinter as well. Pediatric cardiac surgeon Narutoshi Hibino of Johns Hopkins is using Regenova to develop bioprinted heart patches to patch the damaged hearts of patients with heart failure who are unable to cope with medication or receive complex cardiac surgery.
At the Indiana University School of Medicine, Dr. Lester Smith, assistant research professor of radiology and imaging sciences and manager of the school's 3D Bioprinting Core,is engaged in clinical biofabricating projects aimed at repairing bone and tendon damage and nipple tissue generation, as well as liver, pancreatic and breast cancer models for metabolic activity and drug-response analysis.
"The bioprinter holds promise to more naturally reproduce tissues in the body than other current bioprinting methods," said Dr. Smith.
Now, with a staff of 23, the company has eight 3-D printer systems operating at Japanese universities and five in U.S. institutions and companies.
While Cyfuse's prospects seem bright, just how quickly futuristic ideas resembling science-fiction fantasy can be realized is unknown.
"This system has a lot of potential because it is unique in many ways," said Dr. David Yu, vice president of business development at Cell Applications. "To unlock that potential, it's going to take the marriage between the machine and the imagination of scientists.
Beste bezoeker, Heb je zelf al ooit een vreemde waarneming gedaan, laat dit dan even weten via email aan Frederick Delaere opwww.ufomeldpunt.be. Deze onderzoekers behandelen jouw melding in volledige anonimiteit en met alle respect voor jouw privacy. Ze zijn kritisch, objectief maar open minded aangelegd en zullen jou steeds een verklaring geven voor jouw waarneming! DUS AARZEL NIET, ALS JE EEN ANTWOORD OP JOUW VRAGEN WENST, CONTACTEER FREDERICK. BIJ VOORBAAT DANK...
Druk op onderstaande knop om je bestand , jouw artikel naar mij te verzenden. INDIEN HET DE MOEITE WAARD IS, PLAATS IK HET OP DE BLOG ONDER DIVERSEN MET JOUW NAAM...
Druk op onderstaande knop om een berichtje achter te laten in mijn gastenboek
Alvast bedankt voor al jouw bezoekjes en jouw reacties. Nog een prettige dag verder!!!
Over mijzelf
Ik ben Pieter, en gebruik soms ook wel de schuilnaam Peter2011.
Ik ben een man en woon in Linter (België) en mijn beroep is Ik ben op rust..
Ik ben geboren op 18/10/1950 en ben nu dus 73 jaar jong.
Mijn hobby's zijn: Ufologie en andere esoterische onderwerpen.
Op deze blog vind je onder artikels, werk van mezelf. Mijn dank gaat ook naar André, Ingrid, Oliver, Paul, Vincent, Georges Filer en MUFON voor de bijdragen voor de verschillende categorieën...
Veel leesplezier en geef je mening over deze blog.